Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

New Consensus Recommendations Announced for Standardized Imaging Protocol in Brain Tumor Clinical Trials

Brain Tumor Imaging Protocol Will Reduce Variability in Magnetic Resonance Imaging and Increase Accuracy in ...

Read Full Story

SNO Pre-Conference Sessions

November 18 - 19, San Antonio, Texas immediately preceding the SNO Annual Meeting

Read Full Story

NEURO-ONCOLOGY ANNOUNCES NEW IMPACT FACTOR Ranking of 6.776 is highest in journal’s history

    The editorial office of SNO’s flagship journal, Neuro-Oncology, is pleased to announce that the 2015 ...

Read Full Story
View All News

September
17

Asian Society for Neuro-Oncology Annual Meeting (ASNO 2015)

Read Full Story

September
22

Webinar to Discuss New Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Neuro-Oncology Clinical Trials

Read Full Story

October
02

5th Annual Brain Metastases Research and Emerging Therapies Conference

Read Full Story

Neuro-Oncology Impact Factor Rises

The Society for Neuro-Oncology is pleased to announce that the impact factor for Neuro-Oncology has risen to 6.180, putting the journal among the top ten titles in Clinical Neurology by the Science Citation Index.

This new, higher ranking reinforces Neuro-Oncology’s position as the leading journal in the field.

With a wealth of peer-reviewed articles and reviews, topical symposia, abstracts of annual meetings, and society news from around the world, the journal continues its mission to provide superior and rapid publication of information in all areas of neuro-oncology.

The three recent most highly cited papers are free to read via the below links.

 

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

Authors: de Groot, John F.; Fuller, Gregory; Kumar, Ashok J.; et al.

 

A multigene predictor of outcome in glioblastoma

Authors: Colman, Howard; Zhang, Li; Sulman, Erik P.; et al.

 

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Authors: Raizer, Jeffrey J.; Abrey, Lauren E.; Lassman, Andrew B.; et al.

 

For more information

http://neuro-oncology.oxfordjournals.org/